Company Search

Education Flash Analysis

ATHX

ATHERSYS, INC / NEW

NASD, Healthcare, Biotechnology, USA

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. The company was founded in 1995 and is headquartered in Cleveland, Ohio.



Market Cap Shares Float Float Held by Institutions % Shares Outstanding Shares Authorized Institutional Own %
7.48 M 22.42 M 11.36% 26.71 M 600.00 M 11.31%
Date of Short Interest by FINRA Shares Sold Short Short Float % Insider Own % Number Institutions Holding Shares MVPHS
31-Aug-2023 0.80 M 3.63% 0.50% 55 $20.63 M

Financial Doc Link Date of Doc Cash Equivalents Burn Rate Operating Activities (monthly) Operating Expenses (monthly) Estimated Months Left of Cash
10-Q 15-May-2023 $3.12 M $1.99 M $0.94 M -3.43

As a result of recent cash raise, this company now has an estimated $6.81 M cash with 0.00 months of cash remaining.

Current Assets Current Liabilities Working Capital Total Assets Total Liabilities Total Revenues (12 mo)
$7.84 M $39.68 M -$31.85 M $21.63 M Unavailable $0.15 M

Dilutive convertible shares can impact a stock's price by increasing the number of outstanding shares, potentially reducing the value of existing shares and decreasing the stock price.

Sign up to see if this company has convertible shares


Stock Warrants can increase share count when exercised. This dilutions affects earnings per share and potentially reduces stock value and impacting investments.

Sign up to see if this company has dilutive warrants


The liquidity and capital resources provides information on the company's cash position, debt levels, and ability to generate cash, indicating its financial stability and potential for growth.

Sign up to see if this company has a need to raise


Shelf Registrations can impact a stock's price by increasing the supply of shares available for sale, potentially lowering demand and decreasing stock price, leading to decreased returns on investors.

Sign up to see if this company has any shelf registrations


Shelf Registrations can impact a stock's price by increasing the supply of shares available for sale, potentially lowering demand and decreasing stock price, leading to decreased returns on investors.

Sign up to see if this company has any shelf registrations pending effect


Registration Statements, which provide information on a company's financials and business plans before a public offering, can impact trading by affecting investor perception and demand for the stock, potentially leading to price changes.

Sign up to see if this company has any registration statements


Registration Statements, which provide information on a company's financials and business plans before a public offering, can impact trading by affecting investor perception and demand for the stock, potentially leading to price changes.

Sign up to see if this company has any registration statements pending effect


Company current reports can impact investments by providing important information on material events and changes at the company, affecting the stock price and potential for gains or losses.

Sign up to see if this company has any current reports


A company not being Nasdaq compliant can impact trading performance by reducing investor confidence and potentially leading to decreased demand, lower stock price, and decreased liquidity in the market.

Sign up to see if this company has any noncompliance